HER2:?

Nikolas Tauber1, Christoph Cirkel1, Anna Claussen1

  • 1Department of Gynecology and Obstetrics, University Hospital Schleswig-Holstein, Campus Lübeck, 23538 Lübeck, Germany.

Cancers
|March 28, 2024
PubMed
概括

研究人员正在探索 HER2 阳性早期乳腺癌的无化疗选择,旨在减少治疗毒性. 虽然有希望,但将抗HER2疗法与化疗结合在一起仍然是最佳结果的当前标准.